1. Home
  2. GPCR vs ASIC Comparison

GPCR vs ASIC Comparison

Compare GPCR & ASIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPCR
  • ASIC
  • Stock Information
  • Founded
  • GPCR 2016
  • ASIC 2018
  • Country
  • GPCR United States
  • ASIC United States
  • Employees
  • GPCR N/A
  • ASIC N/A
  • Industry
  • GPCR
  • ASIC Property-Casualty Insurers
  • Sector
  • GPCR
  • ASIC Finance
  • Exchange
  • GPCR Nasdaq
  • ASIC Nasdaq
  • Market Cap
  • GPCR 1.1B
  • ASIC 1.1B
  • IPO Year
  • GPCR 2023
  • ASIC 2025
  • Fundamental
  • Price
  • GPCR $21.08
  • ASIC $21.98
  • Analyst Decision
  • GPCR Strong Buy
  • ASIC
  • Analyst Count
  • GPCR 7
  • ASIC 0
  • Target Price
  • GPCR $76.17
  • ASIC N/A
  • AVG Volume (30 Days)
  • GPCR 844.3K
  • ASIC 389.1K
  • Earning Date
  • GPCR 08-07-2025
  • ASIC 01-01-0001
  • Dividend Yield
  • GPCR N/A
  • ASIC N/A
  • EPS Growth
  • GPCR N/A
  • ASIC N/A
  • EPS
  • GPCR N/A
  • ASIC 0.12
  • Revenue
  • GPCR N/A
  • ASIC $350,888,000.00
  • Revenue This Year
  • GPCR N/A
  • ASIC N/A
  • Revenue Next Year
  • GPCR N/A
  • ASIC N/A
  • P/E Ratio
  • GPCR N/A
  • ASIC $198.15
  • Revenue Growth
  • GPCR N/A
  • ASIC 42.48
  • 52 Week Low
  • GPCR $13.22
  • ASIC $21.00
  • 52 Week High
  • GPCR $47.48
  • ASIC $25.30
  • Technical
  • Relative Strength Index (RSI)
  • GPCR 42.73
  • ASIC N/A
  • Support Level
  • GPCR $20.91
  • ASIC N/A
  • Resistance Level
  • GPCR $23.67
  • ASIC N/A
  • Average True Range (ATR)
  • GPCR 1.46
  • ASIC 0.00
  • MACD
  • GPCR 0.04
  • ASIC 0.00
  • Stochastic Oscillator
  • GPCR 21.43
  • ASIC 0.00

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

About ASIC Ategrity Specialty Insurance Company Holdings Common Stock

Ategrity Specialty Insurance Co Holdings Formerly Ategrity Specialty Holdings LLC is a specialty insurance company dedicated to providing excess and surplus products to small to medium-sized businesses across the United States. It offers property and casualty insurance solutions tailored to meet the needs of SMBs. The company focuses on are Real Estate, Hospitality, Construction, and Retail.

Share on Social Networks: